1,998
Views
2
CrossRef citations to date
0
Altmetric
Hepatitis

Profile of clinical characteristics and serologic markers of sporadic hepatitis E in a community cohort study

, , , , , , , , , , , ORCID Icon, , ORCID Icon & ORCID Icon show all
Article: 2140613 | Received 23 Aug 2022, Accepted 21 Oct 2022, Published online: 18 Dec 2022

References

  • Kamar N, Izopet J, Pavio N, et al. Hepatitis E virus infection. Nat Rev Dis Primers. 2017 Nov 16;3:17086. doi:10.1038/nrdp.2017.86
  • The L. Growing concerns of hepatitis E in Europe. Lancet. 2017 Jul 22;390(10092):334.
  • Ren X, Wu P, Wang L, et al. Changing epidemiology of hepatitis A and hepatitis E viruses in China, 1990–2014. Emerg Infect Dis. 2017 Feb;23(2):276–279. doi:10.3201/eid2302.161095
  • Aggarwal R. Diagnosis of hepatitis E. Nat Rev Gastroenterol Hepatol. 2013 Jan;10(1):24–33. doi:10.1038/nrgastro.2012.187
  • Huang S, Zhang X, Jiang H, et al. Profile of acute infectious markers in sporadic hepatitis E. PLoS One. 2010;5(10):e13560. doi:10.1371/journal.pone.0013560
  • Montpellier C, Wychowski C, Sayed IM, et al. Hepatitis E virus lifecycle and identification of 3 forms of the ORF2 capsid protein. Gastroenterology. 2018 Jan;154(1):211–223. doi:10.1053/j.gastro.2017.09.020
  • Zhao C, Geng Y, Harrison TJ, et al. Evaluation of an antigen-capture EIA for the diagnosis of hepatitis E virus infection. J Viral Hepat. 2015 Nov;22(11):957–963. doi:10.1111/jvh.12397
  • Behrendt P, Bremer B, Todt D, et al. Hepatitis E virus (HEV) ORF2 antigen levels differentiate between acute and chronic HEV infection. J Infect Dis. 2016;214(3):361–368. doi:10.1093/infdis/jiw161
  • Geng Y, Zhao C, Huang W, et al. Detection and assessment of infectivity of hepatitis E virus in urine. J Hepatol. 2016 Jan;64(1):37–43. doi:10.1016/j.jhep.2015.08.034
  • Wen GP, Tang ZM, Yang F, et al. A valuable antigen detection method for diagnosis of acute hepatitis E. J Clin Microbiol. 2015;53(3):782–788. doi:10.1128/JCM.01853-14
  • Tremeaux P, Lhomme S, Chapuy-Regaud S, et al. Performance of an antigen assay for diagnosing acute hepatitis E virus genotype 3 infection. J Clin Virol. 2016 Jun;79:1–5. doi:10.1016/j.jcv.2016.03.019
  • Lapa D, Brega C, Mammone A, et al. Diagnostic performance of hepatitis E virus antigen assay in hepatitis E virus acute infection. New Microbiol. 2016 Oct;40(4):246–250.
  • Fontana RJ, Engle RE, Scaglione S, et al. The role of hepatitis E virus infection in adult Americans with acute liver failure. Hepatology. 2016 Dec;64(6):1870–1880. doi:10.1002/hep.28649
  • Romano L, Paladini S, Tagliacarne C, et al. Hepatitis E in Italy: a long-term prospective study. J Hepatol. 2011 Jan;54(1):34–40. doi:10.1016/j.jhep.2010.06.017
  • Yin X, Ying D, Lhomme S, et al. Origin, antigenicity, and function of a secreted form of ORF2 in hepatitis E virus infection. Proc Natl Acad Sci USA. 2018;115(18):4773. doi:10.1073/pnas.1721345115
  • Rydell GE, Prakash K, Norder H, et al. Hepatitis B surface antigen on subviral particles reduces the neutralizing effect of anti-HBs antibodies on hepatitis B viral particles in vitro. Virology. 2017 Sep;509:67–70. doi:10.1016/j.virol.2017.05.017
  • Cornberg M, Wong VW, Locarnini S, et al. The role of quantitative hepatitis B surface antigen revisited. J Hepatol. 2017;66(2):398–411. doi:10.1016/j.jhep.2016.08.009
  • Aggarwal R, Kini D, Sofat S, et al. Duration of viraemia and faecal viral excretion in acute hepatitis E. Lancet. 2000;356(9235):1081–1082. doi:10.1016/S0140-6736(00)02737-9
  • Sridhar S, Lo SK, Xing F, et al. Clinical characteristics and molecular epidemiology of hepatitis E in Shenzhen, China: a shift toward foodborne transmission of hepatitis E virus infection. Emerg Microbes Infect. 2017 Dec 20;6(12):e115.
  • Wang L, Liu L, Wei Y, et al. Clinical and virological profiling of sporadic hepatitis E virus infection in China. J Infect. 2016 Sep;73(3):271–279. doi:10.1016/j.jinf.2016.06.005
  • El-Mokhtar MA, Karam-Allah Ramadan H, Abdel Hameed MR, et al. Evaluation of hepatitis E antigen kinetics and its diagnostic utility for prediction of the outcomes of hepatitis E virus genotype 1 infection. Virulence. 2021 Dec;12(1):1334–1344. doi:10.1080/21505594.2021.1922027
  • Khan AI, Salimuzzaman M, Islam MT, et al. Nationwide hospital-based seroprevalence of hepatitis A and hepatitis E virus in Bangladesh. Ann Glob Health. 2020 Mar 16;86(1):29. doi:10.5334/aogh.2574
  • Zhu FC, Huang SJ, Wu T, et al. Epidemiology of zoonotic hepatitis E: a community-based surveillance study in a rural population in China. PLoS One. 2014;9(1):e87154. doi:10.1371/journal.pone.0087154
  • Zhang J, Zhang XF, Huang SJ, et al. Long-term efficacy of a hepatitis E vaccine. N Engl J Med. 2015 Mar 05;372(10):914–922. doi:10.1056/NEJMoa1406011
  • Zhu FC, Zhang J, Zhang XF, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet. 2010 Sep 11;376(9744):895–902. doi:10.1016/S0140-6736(10)61030-6
  • Zhang J, Zhang XF, Zhou C, et al. Protection against hepatitis E virus infection by naturally acquired and vaccine-induced immunity. Clin Microbiol Infect. 2014 Jun;20(6):O397–O405. doi:10.1111/1469-0691.12419
  • Jothikumar N, Cromeans TL, Robertson BH, et al. A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus. J Virol Methods. 2006 Jan;131(1):65–71. doi:10.1016/j.jviromet.2005.07.004
  • Wen GP, Tang ZM, Wang SL, et al. Classification of human and zoonotic group hepatitis E virus (HEV) using antigen detection. Appl Microbiol Biotechnol. 2017 Oct 16;101(23-24):8585–8594. doi:10.1007/s00253-017-8526-8
  • Myint KSA, Endy TP, Shrestha MP, et al. Hepatitis E antibody kinetics in Nepalese patients. Trans R Soc Trop Med Hyg. 2006;100(10):938–941. doi:10.1016/j.trstmh.2005.12.005
  • Clayson ET, Myint KS, Snitbhan R, et al. Viremia, fecal shedding, and IgM and IgG responses in patients with hepatitis E. J Infect Dis. 1995 Oct;172(4):927–933. doi:10.1093/infdis/172.4.927
  • Chandra NS, Sharma A, Malhotra B, et al. Dynamics of HEV viremia, fecal shedding and its relationship with transaminases and antibody response in patients with sporadic acute hepatitis E. Virol J. 2010;7:213. doi:10.1186/1743-422X-7-213
  • Al-Sadeq DW, Majdalawieh AF, Mesleh AG, et al. Laboratory challenges in the diagnosis of hepatitis E virus. J Med Microbiol. 2018 Apr;67(4):466–480. doi:10.1099/jmm.0.000706
  • http://www.dongtai.gov.cn/art/2012/2/16/art_7306_1336265.html.
  • Sarin SK, Kumar M, Eslam M, et al. Liver diseases in the Asia-Pacific region: a lancet gastroenterology & hepatology commission. Lancet Gastroenterol Hepatol. 2020 Feb;5(2):167–228. doi:10.1016/S2468-1253(19)30342-5
  • Teixeira J, Mesquita JR, Pereira SS, et al. Prevalence of hepatitis E virus antibodies in workers occupationally exposed to swine in Portugal. Med Microbiol Immunol. 2017 Feb;206(1):77–81. doi:10.1007/s00430-016-0484-8
  • Capai L, Masse S, Gallian P, et al. Seroprevalence study of anti-HEV IgG among different adult populations in Corsica, France, 2019. Microorganisms. 2019 Oct;7(10). doi:10.3390/microorganisms7100460